In vivo modification of the UDP-glucuronosyltransferase functional state in rat liver following hypophysectomy and partial or complete hormonal restoration.
The effects of growth hormone on the uridine diphosphate glucuronosyltransferase functional state, biophysical membrane parameters (order parameters and rotational correlation frequency) and the composition in phospholipids were studied in male rat hepatic microsomes. Sham-operated and hypophysectomized animals were injected with two different dosages of growth hormone, mimicking either the male or female growth hormone secretion pattern. Half the animals received thyroxine and cortisol in concentrations chosen to compensate for the lack of thyroid hormones and glucocorticoids in hypophysectomized rats. Growth hormone treatment resulted in a decrease in the latency (that gives a quantification of uridine diphosphate glucuronosyltransferase functional state) of the glucuronidation activities towards various substrates (testosterone, androsterone, bilirubin and 4-nitrophenol). This decrease with growth hormone treatment was particularly evident in hypophysectomized animals that had received cortisol and thyroxine supplementation treatment. These modifications were strongly correlated with modifications in the microsomal membrane lysophospholipid content and to a lower extent with microsomal membrane fatty acid composition. The cytosolic phospholipase A(2)-dependent increase in the lysophospholipid content in the endoplasmic reticulum is probably a major determinant in the regulation of the functional state of glucuronoyltransferases in response to high dosage growth hormone treatment.
Guéraud
Françoise
F
Laboratoire des Xénobiotiques, Institut National de la Recherche Agronomique (INRA), 180 chemin de Tournefeuille, B.P. 3, 31931 Toulouse Cédex 9, France. fgueraud@toulouse.inra.fr
Daveloose
Denis
D
Vezin
Hervé
H
Viret
Jacques
J
Paris
Alain
A
D000818:Animals; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D014453:Glucuronosyltransferase / Q000378:metabolism*; D013006:Growth Hormone / Q000494:pharmacology* / Q000502:physiology; D006854:Hydrocortisone / Q000494:pharmacology; D007016:Hypophysectomy; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008246:Lysophospholipids / Q000502:physiology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013974:Thyroxine / Q000494:pharmacology
D005227:Fatty Acids; D008246:Lysophospholipids; D013006:Growth Hormone; D014453:Glucuronosyltransferase; D013974:Thyroxine; D006854:Hydrocortisone